Johns Hopkins hires investigator amid children’s hospital scandal

A former federal prosecutor has been appointed to lead an investigation into the Johns Hopkins All Children’s Hospital heart surgery unit, The Tampa Bay Times reported. The hospital, based in St. Petersburg, Florida, has been the focus of a scandal after a recent Tampa Bay Times investigation revealed the unit’s mortality rate had tripled in just a few years.

The report led to a number of resignations of executives within the hospital.

The investigator, F. Joseph Warin of Global Dunn, will review the deaths at the children’s hospital and other problems and report to a special committee of the board of trustees by May, the report said. The health system also plans to appoint an independent monitor at the St. Petersburg hospital.

After uncovering significant problems at the children’s hospital, the Tampa Bay Times dug further into Johns Hopkins and found other safety issues across its Baltimore-based hospital and five sister hospitals in early January.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.